Portfolio & Fund News
DadeSystems announced that Bill Wardwell has joined the company as President, where he will be responsible for driving DadeSystems’ corporate strategy, sales, marketing, and business development.
Iowa City Schools leverage itopia to transcend on-site Windows labs and deliver virtual education to remote students on Chromebooks
Iowa City Schools, known for staying ahead of the curve with innovative curriculum tools, leveraged itopia and Google Cloud to implement a more scalable, resilient, and easy-to-manage system for delivering educational applications to thousands of students.
itopia, the leading cloud automation and orchestration solution for Google Cloud, today announced the expanded capabilities of its SaaS platform to deploy and manage Windows 10 Client OS virtual desktops and apps.
Senecio Robotics awarded US$12 Million from the European Commission to address mosquito borne diseases
The Israeli early stage company, AI award winner, Senecio Ltd. develops a mobile automated mosquito factory for monitoring and control of mosquitoes.
itopia, a leading SaaS solution for virtual desktops and apps on Google Cloud, enables Artnet to easily provide its employees with secure, remote workstations and downsize its data center footprint.
Co-Founder and CEO of Fortify, an advanced manufacturing startup that aims to disrupt additive manufacturing.
itopia, provider of the leading cloud automation and orchestration solution for Google Cloud, has engaged with healthcare technology transformation provider Cognosante, to deploy virtual desktops and apps on Google Cloud for its remote, contact center quality assurance workforce.
Aegle Therapeutics Announces Award of Grant by U.S. Department of Defense’s (“DoD”) Congressionally Directed Medical Research Programs (“CDMRP”) for Development of AGLE-102
The CDMRP grant will fund a phase 1/2a clinical trial in burn patients using Aegle’s extracellular vesicle therapy.
FDA Grants Fast Track Status to Aegle Therapeutics’ AGLE-102 for the Treatment of Dystrophic Epidermolysis Bullosa
Aegle Therapeutics Corporation today announced the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to AGLE-102
While the pandemic has obviously been a hard-hitting operational disruption on top of the devastating health consequences so many have faced, Fortify has achieved its goals anyway — and then some.